학술논문
First-in-human study demonstrating the safety and clinical efficacy of novel anti-IL-17A monoclonal antibody CJM112 in moderate to severe plaque psoriasis
Document Type
Article
Author
Source
In: Journal of the European Academy of Dermatology and Venereology . (Journal of the European Academy of Dermatology and Venereology, May 2021, 35(5):1143-1151)
Subject
Language
English
ISSN
14683083
09269959
09269959